Motivated by their previous finding of the presence of P - glycoprotein overexpression in the nasal lining of patients with CRS with nasal polyps, the study authors conducted a randomized, double - blind, placebo - controlled clinical trial studying the use of low - dose
Verapamil in 18 patients with CRS with nasal polyps.
Not exact matches
The researchers found that adding
verapamil augmented the potency of bedaquiline and accelerated its ability to clear mycobacteria
in mice.
The clinical trial results, published online
in the Journal of Allergy and Clinical Immunology: In Practice, suggest that Verapamil represents a promising novel therapy for the treatment of CRS with nasal polyp
in the Journal of Allergy and Clinical Immunology:
In Practice, suggest that Verapamil represents a promising novel therapy for the treatment of CRS with nasal polyp
In Practice, suggest that
Verapamil represents a promising novel therapy for the treatment of CRS with nasal polyps.
A clinical trial studying the use of
Verapamil (a drug currently
in use for cardiovascular disease and cluster headache)
in alleviating chronic rhinosinusitis (CRS) with nasal polyps revealed significant improvement
in the symptoms of this subset of patients.
Researchers at the Chemical Abuse Centers
in Boardman, Ohio, found that combining magnesium oxide with the drug
verapamil helped control manic symptoms
in patients better than a drug - placebo combination.
An analysis of these patients demonstrated improved outcomes for those
in the
Verapamil group
in relation to those
in the placebo group.
While Sentinel is safe to use
in dogs at risk for MDRI - allele mutation (Australian Shepherds, Collies, Shelties, etc.), unless tested normal, caution is advised if your pet is also being given amiodarone (Cordarone), azole antifungals such as ketoconazole, carvedilol (Coreg), cyclosporine (Atopica), diltiazem (Cardizem), erythromycin (Ery - Tabs) or clarithromycin (Biaxin), quinidine, spironolactone (Aldactone), tamoxifen, and
verapamil (Calan).